BAM
RMD icon

Belpointe Asset Management’s ResMed RMD Stock Holding History

Belpointe Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$576K Buy
2,958
+147
+5% +$30.5K 0.02% 672
2026
Q1 		$631K Buy
2,811
+811
+41% +$202K 0.02% 615
2025
Q4 		$482K Sell
2,000
-748
-27% -$191K 0.02% 668
2025
Q3 		$752K Buy
+2,748
New +$751K 0.03% 497
2023
Q2 		– Sell
-488
Closed -$107K – 2762
2023
Q1 		$107K Sell
488
-76
-13% -$16.5K 0.01% 1263
2022
Q4 		$117K Sell
564
-316
-36% -$69.4K 0.01% 1157
2022
Q3 		$192K Buy
+880
New +$200K 0.01% 859

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Belpointe Asset Management's RMD Position: Q2 2026 in Review

Belpointe Asset Management increased its ResMed (RMD) stake by 5.2% in Q2 2026, buying an estimated $30.5K and bringing the position to 2,958 shares worth $576K. The position accounts for 0.02% of the portfolio, ranked #672.

Belpointe Asset Management first reported a position in RMD in Q3 2022 and has held it in 7 quarters since. The position peaked at $752K in Q3 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Belpointe Asset Management held 2,958 shares of ResMed worth $576K as of Q2 2026.
  • Belpointe Asset Management bought 147 ResMed shares in Q2 2026, an estimated $30.5K.
  • ResMed made up 0.02% of Belpointe Asset Management's portfolio in Q2 2026, its #672 holding.
  • Belpointe Asset Management first reported a position in ResMed in Q3 2022 and has held it in 7 quarters since.
  • Belpointe Asset Management's ResMed position peaked at $752K in Q3 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.